Overview
Tapentadol is a centrally-acting analgesic with dual mu-opioid receptor agonist and norepinephrine reuptake inhibitor activity, indicated for management of acute pain severe enough to require opioid therapy when alternative treatments are inadequate. It provides opioid-level analgesia while potentially offering improved gastrointestinal tolerability compared to traditional opioids.
Mechanism of Action
Tapentadol exerts its analgesic effects through two complementary mechanisms: (1) mu-opioid receptor agonism similar to traditional opioids, and (2) inhibition of norepinephrine reuptake, which enhances descending inhibitory pain pathways in the central nervous system.
Indications
- Management of acute pain severe enough to require an opioid analgesic in adults
- Use only when alternative non-opioid treatments are ineffective, not tolerated, or would be otherwise inadequate
Common Doses
- 50 mg
- 75 mg
- 100 mg
Dosage
Individualized based on pain severity and patient response. Typically initiated at 50-100 mg every 4-6 hours as needed for pain, with maximum daily dose of 700 mg on first day and 600 mg on subsequent days. Dose adjustments required for hepatic impairment.
Contraindications
- Significant respiratory depression
- Acute or severe bronchial asthma in unmonitored setting or without resuscitative equipment
- Known or suspected gastrointestinal obstruction, including paralytic ileus
- Hypersensitivity to tapentadol or any product ingredients
- Concurrent use of MAOIs or within 14 days of MAOI use
Side Effects
- Nausea, vomiting, constipation, dizziness, somnolence
- Pruritus, dry mouth, headache, fatigue
- Serious adverse reactions: respiratory depression, addiction, withdrawal, seizures
- Gastrointestinal adverse reactions including paralytic ileus
- Opioid-induced hyperalgesia and allodynia
Interactions
- Benzodiazepines and other CNS depressants: increased risk of respiratory depression and sedation
- Serotonergic drugs (SSRIs, SNRIs, TCAs, triptans): risk of serotonin syndrome
- MAOIs: contraindicated due to risk of serotonin syndrome or opioid toxicity
- Mixed agonist/antagonist opioids: may reduce analgesic effect or precipitate withdrawal
- Muscle relaxants: enhanced neuromuscular blockade and respiratory depression
- Alcohol and other opioids: additive CNS depression effects
Counseling Points
- Take only as prescribed; do not increase dose or frequency without medical advice
- Avoid alcohol and other CNS depressants while taking this medication
- Do not crush, chew, or break tablets - swallow whole
- May cause dizziness or drowsiness - avoid driving or operating machinery until effects are known
- Store securely to prevent misuse, abuse, or accidental ingestion by others
- Dispose of unused medication properly
- Seek immediate medical attention for signs of overdose: slow breathing, extreme sleepiness, inability to wake up